investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Cancer transcriptome characterization using massively parallel DNA sequencing
Marco A Marra
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Marco A Marra
Canada's Michael Smith Genome Sciences Centre
Vancouver, Canada
BC Cancer Agency
Vancouver, Canada
Related projects
Forest M White
FASEB SRC on Protein Kinases, Cellular Plasticity and Signal Rewiring
All cancers but non-melanoma skin cancer
James McMahon
Molecular Targets Laboratory
All cancers but non-melanoma skin cancer
Bruce Shapiro
Computational and Experimental RNA Nanobiology
All cancers but non-melanoma skin cancer
Mitsuhiko Ikura
Protein structure and protein interactions (CANADA RESEARCH CHAIRHOLDER)
All cancers but non-melanoma skin cancer
Patrick O'Donoghue
CRC Tier 2 - Protein modifications Signalling
All cancers but non-melanoma skin cancer
Rosalie C Sears
Cellular Mechanisms Controlling Myc Protein Stability
All cancers but non-melanoma skin cancer
Caryn Lerman
Pharmacogenetics of Nicotine Addiction Treatment
All cancers but non-melanoma skin cancer
Chantal Guillemette
Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)
All cancers but non-melanoma skin cancer
Maya Shmulevitz
CRC Tier 2 - Human Reovirus
All cancers but non-melanoma skin cancer